000 | 02947 a2200817 4500 | ||
---|---|---|---|
005 | 20250514155119.0 | ||
264 | 0 | _c20040607 | |
008 | 200406s 0 0 eng d | ||
022 | _a1350-9047 | ||
024 | 7 |
_a10.1038/sj.cdd.4401285 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGlantschnig, H | |
245 | 0 | 0 |
_aM-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase. _h[electronic resource] |
260 |
_bCell death and differentiation _cOct 2003 |
||
300 |
_a1165-77 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAcid Phosphatase _xmetabolism |
650 | 0 | 4 |
_aActins _xmetabolism |
650 | 0 | 4 | _aAdaptor Proteins, Signal Transducing |
650 | 0 | 4 |
_aAlendronate _xpharmacology |
650 | 0 | 4 |
_aAlkyl and Aryl Transferases _xantagonists & inhibitors |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aBone Marrow Cells _xcytology |
650 | 0 | 4 |
_aBone Resorption _xmetabolism |
650 | 0 | 4 |
_aCarrier Proteins _xmetabolism |
650 | 0 | 4 | _aCaspase 3 |
650 | 0 | 4 | _aCaspase 9 |
650 | 0 | 4 |
_aCaspases _xmetabolism |
650 | 0 | 4 | _aCell Cycle Proteins |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aCollagen _xmetabolism |
650 | 0 | 4 | _aCollagen Type I |
650 | 0 | 4 |
_aCytokines _xpharmacology |
650 | 0 | 4 |
_aDiterpenes _xpharmacology |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aEukaryotic Initiation Factors |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aInterleukin-1 _xpharmacology |
650 | 0 | 4 |
_aIsoenzymes _xmetabolism |
650 | 0 | 4 |
_aMacrophage Colony-Stimulating Factor _xpharmacology |
650 | 0 | 4 |
_aMembrane Glycoproteins _xpharmacology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aNF-kappa B _xanalysis |
650 | 0 | 4 |
_aOsteoclasts _xcytology |
650 | 0 | 4 |
_aPeptides _xmetabolism |
650 | 0 | 4 |
_aPhosphoproteins _xmetabolism |
650 | 0 | 4 |
_aProtein Kinases _xphysiology |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xmetabolism |
650 | 0 | 4 |
_aProtein Synthesis Inhibitors _xpharmacology |
650 | 0 | 4 |
_aProto-Oncogene Proteins _xanalysis |
650 | 0 | 4 | _aProto-Oncogene Proteins c-akt |
650 | 0 | 4 | _aRANK Ligand |
650 | 0 | 4 | _aReceptor Activator of Nuclear Factor-kappa B |
650 | 0 | 4 |
_aRibosomal Protein S6 _xmetabolism |
650 | 0 | 4 |
_aRibosomal Protein S6 Kinases, 70-kDa _xmetabolism |
650 | 0 | 4 | _aSerine-Threonine Kinase 3 |
650 | 0 | 4 |
_aSignal Transduction _xphysiology |
650 | 0 | 4 |
_aSirolimus _xpharmacology |
650 | 0 | 4 | _aTOR Serine-Threonine Kinases |
650 | 0 | 4 | _aTartrate-Resistant Acid Phosphatase |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
700 | 1 | _aFisher, J E | |
700 | 1 | _aWesolowski, G | |
700 | 1 | _aRodan, G A | |
700 | 1 | _aReszka, A A | |
773 | 0 |
_tCell death and differentiation _gvol. 10 _gno. 10 _gp. 1165-77 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.cdd.4401285 _zAvailable from publisher's website |
999 |
_c14263528 _d14263528 |